Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
AZIMILIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
AZIMILIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
74QU6P2934
Molecule Type:
Small molecule
Molecular Formula:
C23H28ClN5O3
Molecular Weight:
457.96
AlogP:
3.23
PSA:
72.6
HBD:
0.0
HBA:
#RotB:
8.0
Source:
TEPRENONE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TEPRENONE
×
Maximum Phase:
3
First Approval:
None
UNII:
S8S8451A4O
Molecule Type:
Small molecule
Molecular Formula:
C46H76O2
Molecular Weight:
661.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ACOLBIFENE
(3)
Small molecule
Estrogen receptor modulator
Unknown
Investigational
Unknown
ACOLBIFENE
×
Maximum Phase:
3
First Approval:
None
UNII:
815LJ9X0D1
Molecule Type:
Small molecule
Molecular Formula:
C29H31NO4
Molecular Weight:
457.57
AlogP:
6.03
PSA:
62.16
HBD:
2.0
HBA:
#RotB:
6.0
Source:
FENOVERINE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
FENOVERINE
×
Maximum Phase:
3
First Approval:
None
UNII:
N274ZQ6PZJ
Molecule Type:
Small molecule
Molecular Formula:
C26H25N3O3S
Molecular Weight:
459.57
AlogP:
4.36
PSA:
45.25
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FLUOROMETHYLCHOLINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLUOROMETHYLCHOLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
6029HGL0QP
Molecule Type:
Small molecule
Molecular Formula:
C6H15FNO+
Molecular Weight:
136.19
AlogP:
0.64
PSA:
9.23
HBD:
0.0
HBA:
#RotB:
4.0
Source:
AMBROXOL ACEFYLLINATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
AMBROXOL ACEFYLLINATE
×
Maximum Phase:
3
First Approval:
None
UNII:
0HM1E174TN
Molecule Type:
Small molecule
Molecular Formula:
C22H28Br2N6O5
Molecular Weight:
616.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZOSUQUIDAR
(3)
Small molecule
P-glycoprotein 1 inhibitor
Unknown
Investigational
Unknown
ZOSUQUIDAR
×
Maximum Phase:
3
First Approval:
None
UNII:
AB5K82X98Y
Molecule Type:
Small molecule
Molecular Formula:
C32H31F2N3O2
Molecular Weight:
527.62
AlogP:
5.21
PSA:
48.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BIGUANIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BIGUANIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
FB4Q52I9K2
Molecule Type:
Small molecule
Molecular Formula:
C2H7N5
Molecular Weight:
101.11
AlogP:
-1.64
PSA:
111.77
HBD:
5.0
HBA:
#RotB:
0.0
Source:
ASOPRISNIL
(3)
Small molecule
Progesterone receptor modulator
Unknown
Investigational
Unknown
ASOPRISNIL
×
Maximum Phase:
3
First Approval:
None
UNII:
72W09924WP
Molecule Type:
Small molecule
Molecular Formula:
C28H35NO4
Molecular Weight:
449.59
AlogP:
5.43
PSA:
68.12
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NARLAPREVIR
(3)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Investigational
Unknown
NARLAPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
2857LA2O07
Molecule Type:
Small molecule
Molecular Formula:
C36H61N5O7S
Molecular Weight:
707.98
AlogP:
3.62
PSA:
170.85
HBD:
4.0
HBA:
#RotB:
13.0
Source:
L-CITRULLINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
L-CITRULLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
29VT07BGDA
Molecule Type:
Small molecule
Molecular Formula:
C6H13N3O3
Molecular Weight:
175.19
AlogP:
-1.15
PSA:
118.44
HBD:
4.0
HBA:
#RotB:
5.0
Source:
DINACICLIB
(3)
Small molecule
Cyclin-dependent kinase 1 inhibitor
Unknown
Investigational
Unknown
DINACICLIB
×
Maximum Phase:
3
First Approval:
None
UNII:
4V8ECV0NBQ
Molecule Type:
Small molecule
Molecular Formula:
C21H28N6O2
Molecular Weight:
396.5
AlogP:
2.28
PSA:
92.63
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DAPACONAZOLE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
DAPACONAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
H2976538CX
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2F3N2O
Molecular Weight:
415.24
AlogP:
6.17
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ALIZAPRIDE
(3)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Investigational
Unknown
ALIZAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
P55703ZRZY
Molecule Type:
Small molecule
Molecular Formula:
C16H21N5O2
Molecular Weight:
315.38
AlogP:
1.35
PSA:
83.14
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ARGININE GLUTAMATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARGININE GLUTAMATE
×
Maximum Phase:
3
First Approval:
None
UNII:
TU1X77K34Q
Molecule Type:
Small molecule
Molecular Formula:
C11H23N5O6
Molecular Weight:
321.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BLONANSERIN
(3)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Approved
Unknown
BLONANSERIN
×
Maximum Phase:
3
First Approval:
None
UNII:
AQ316B4F8C
Molecule Type:
Small molecule
Molecular Formula:
C23H30FN3
Molecular Weight:
367.51
AlogP:
4.69
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PIPAMPERONE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PIPAMPERONE
×
Maximum Phase:
3
First Approval:
None
UNII:
5402501F0W
Molecule Type:
Small molecule
Molecular Formula:
C21H30FN3O2
Molecular Weight:
375.49
AlogP:
2.59
PSA:
66.64
HBD:
1.0
HBA:
#RotB:
7.0
Source:
IMLUNESTRANT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
IMLUNESTRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIRTOBRUTINIB
(3)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Approved
Unknown
PIRTOBRUTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
JNA39I7ZVB
Molecule Type:
Small molecule
Molecular Formula:
C22H21F4N5O3
Molecular Weight:
479.43
AlogP:
3.43
PSA:
125.26
HBD:
3.0
HBA:
#RotB:
7.0
Source:
SELATOGREL
(3)
Small molecule
Purinergic receptor P2Y12 antagonist
Unknown
Investigational
Unknown
SELATOGREL
×
Maximum Phase:
3
First Approval:
None
UNII:
6DPK7O4PR7
Molecule Type:
Small molecule
Molecular Formula:
C28H39N6O8P
Molecular Weight:
618.63
AlogP:
1.73
PSA:
174.73
HBD:
3.0
HBA:
#RotB:
11.0
Source:
ADMILPARANT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ADMILPARANT
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BICIFADINE
(3)
Small molecule
Monoamine transporter inhibitor
Unknown
Investigational
Unknown
BICIFADINE
×
Maximum Phase:
3
First Approval:
None
UNII:
B0SV3N7J3H
Molecule Type:
Small molecule
Molecular Formula:
C12H15N
Molecular Weight:
173.26
AlogP:
1.86
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CILEXETIL
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CILEXETIL
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C10H18O3
Molecular Weight:
186.25
AlogP:
2.88
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CEFTOBIPROLE MEDOCARIL
(3)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Investigational
Unknown
CEFTOBIPROLE MEDOCARIL
×
Maximum Phase:
3
First Approval:
None
UNII:
N99027V28J
Molecule Type:
Small molecule
Molecular Formula:
C26H26N8O11S2
Molecular Weight:
690.67
AlogP:
-0.54
PSA:
264.3
HBD:
4.0
HBA:
#RotB:
8.0
Source:
DAPRODUSTAT
(3)
Small molecule
Hypoxia-inducible factor prolyl hydroxylase inhibitor
Unknown
Approved
Unknown
DAPRODUSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
JVR38ZM64B
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O6
Molecular Weight:
393.44
AlogP:
1.26
PSA:
124.09
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FILIBUVIR
(3)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
FILIBUVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
198J479Y2L
Molecule Type:
Small molecule
Molecular Formula:
C29H37N5O3
Molecular Weight:
503.65
AlogP:
5.12
PSA:
102.5
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BITOPERTIN
(3)
Small molecule
Glycine transporter 1 inhibitor
Unknown
Investigational
Unknown
BITOPERTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Q8L6AN59YY
Molecule Type:
Small molecule
Molecular Formula:
C21H20F7N3O4S
Molecular Weight:
543.46
AlogP:
3.94
PSA:
79.81
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TROFINETIDE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
TROFINETIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
Z2ME8F52QL
Molecule Type:
Small molecule
Molecular Formula:
C13H21N3O6
Molecular Weight:
315.33
AlogP:
-1.24
PSA:
150.03
HBD:
4.0
HBA:
#RotB:
7.0
Source:
RETOSIBAN
(3)
Small molecule
Oxytocin receptor antagonist
Unknown
Investigational
Unknown
RETOSIBAN
×
Maximum Phase:
3
First Approval:
None
UNII:
GIE06H28OX
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O5
Molecular Weight:
494.59
AlogP:
2.04
PSA:
104.98
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CENTANAFADINE HYDROCHLORIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CENTANAFADINE HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
265DN9X85W
Molecule Type:
Small molecule
Molecular Formula:
C15H16ClN
Molecular Weight:
245.75
AlogP:
2.7
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
GIREDESTRANT
(3)
Small molecule
Estrogen receptor alpha degrader
Unknown
Investigational
Unknown
GIREDESTRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
28P3DU6DB3
Molecule Type:
Small molecule
Molecular Formula:
C27H31F5N4O
Molecular Weight:
522.56
AlogP:
4.87
PSA:
54.53
HBD:
3.0
HBA:
#RotB:
9.0
Source:
TRIPTOLIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIPTOLIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
19ALD1S53J
Molecule Type:
Small molecule
Molecular Formula:
C20H24O6
Molecular Weight:
360.41
AlogP:
1.1
PSA:
84.12
HBD:
1.0
HBA:
#RotB:
1.0
Source:
AMRUBICIN HYDROCHLORIDE
(3)
Small molecule
DNA topoisomerase II alpha inhibitor
Unknown
Investigational
Unknown
AMRUBICIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
EUL6MP8FZW
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClNO9
Molecular Weight:
519.93
AlogP:
0.63
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
IDAZOXAN
(3)
Small molecule
Adrenergic receptor alpha-2 antagonist
Unknown
Investigational
Unknown
IDAZOXAN
×
Maximum Phase:
3
First Approval:
None
UNII:
Y310PA316B
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
0.83
PSA:
42.85
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ANTIMONY CATION (5+)
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ANTIMONY CATION (5+)
×
Maximum Phase:
3
First Approval:
None
UNII:
841L03HG64
Molecule Type:
Small molecule
Molecular Formula:
Sb+5
Molecular Weight:
121.76
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BRILAROXAZINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BRILAROXAZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
194
195
196
197
198
199
200
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA